This Consortium is composed of 40 participants from 14 countries and addresses three important topics: 1)Patient reported outcome measures to improve management of acute and chronic pain (PROMPT); 2)Pharmacological validation of functional pain biomarkers in healthy subjects and animals (BioPain); 3)Improving translation in chronic pelvic pain (TRiPP)
I facilitated a session that focused on the patient experience of chronic pelvic pain to highlight the issues patients face with the condition.